跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ATORVASTATINA SANDOZ 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ATORVASTATINA SANDOZ 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
ATORVASTATINA SANDOZ 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Sandoz Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 10, 2022
Approval ID
35db2119b4e8ac45
Company
Sandoz Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
35db2119b4e8ac45
Drug Cima Aemps Name
ATORVASTATINA SANDOZ 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
86611
Holder Company Name
Sandoz Farmaceutica S.A.
Marketing Company Name
Sandoz Farmaceutica S.A.
Authorization Date
2022-05-10
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Sandoz Farmaceutica S.A.
Active Ingredients
ATORVASTATINA CALCICA TRIHIDRATO
10,85 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 10, 2022
Approval ID
35db2119b4e8ac45
Type
Standard
Back to CIMA-AEMPS Approvals